濮阳东方医院男科割包皮手术收费标准-【濮阳东方医院】,濮阳东方医院,濮阳东方医院妇科技术专业,濮阳东方医院割包皮评价很高,濮阳东方医院男科医生电话,濮阳东方医院男科割包皮好吗,濮阳东方医院专家怎么样,濮阳东方医院妇科值得选择
濮阳东方医院男科割包皮手术收费标准濮阳东方男科医院割包皮比较好,濮阳东方医院治早泄很正规,濮阳东方医院男科治疗阳痿技术权威,濮阳东方男科医院口碑高,濮阳东方医院看男科病评价比较高,濮阳东方医院男科看阳痿非常便宜,濮阳东方医院男科口碑非常好
A smartphone app says it can help its users stay flu-free.Sickweather relies on user-generated reports to track trending illnesses and where they are spreading around the user's location.The app asks users what symptoms they are currently experiencing. That information is then added to a map that allows users to see if there are other disease outbreaks in the area.The app also includes helpful tips on how to avoid getting the flu.Representatives for the app say that reports of a cough, allergies, and fever can help them forecast an outbreak up to 15 weeks in advance.Sickweather is free and available for download in both the iTunes and Google?Play stores. 727
A new social media trend has one West Michigan photographer capturing the reactions of two people meeting for the very first time in a hybrid blind date/photoshoot.Hailey Estill started shooting photos professionally just a few months ago. She has been working to get her business Candid Captures by Hayley off the ground in a few different ways.Estill graduated from college with a degree in psychology and has been looking into how she can meld her passion for creative photography with her knowledge of how the human mind works.And so, in a poetic meshing of her different skill sets, she began arranging and shooting what she calls "stranger shoots".Estill says she is "interested in both the art and the psyche behind two people meeting and getting intimate pictures taken.”On Monday evening she let FOX 17 tag along on her latest shoot.“They're all gonna have different outcomes, because you're just doing it with completely different people every time,” Estill said.At this shoot, a man and a woman from Grand Rapids would meet for the very first time, as Estill hangs back and takes a series of photos that could easily be confused for an engagement shoot.Danny and Caitlin, both in their early twenties, walked towards each other with their faces covered by bandannas.Estill says she will often give the participants prompts while shooting, telling them to whisper different trivia facts about themselves to one another.“So I’m going to tell you guys to go in the middle of the road there and slow dance for a minute," Estill told Danny and Caitlin during their photoshoot at Crescent Park in downtown Grand Rapids."And then Danny, you go first and tell her 3 things about you. And after, I want you to tell him 3 things about you."While Estill says not every couple ends up hitting it off right away, Danny and Caitlin seemed quite smitten.“I think I'm a pretty outgoing person, easy to get along with. So this wasn't super out of my comfort zone. I'm pretty good right now, I don't know about him," Caitlin said after the photoshoot finished up."The entire time I was kind of just like, Wow, she's beautiful. Like, I can't wait to get to know her," Danny added. “I hope there's something here… I mean, I have good feelings about this.”The pair exchanged contact info before the sun went down.“He walked her to her car, so I don't know what’s happening," Estill said after the couple had departed.Estill says she doesn't see her playing cupid as a long-term career path, but for now, she is enjoying it and looking forward to booking more "stranger shoots" in the near future.She said, “You just never know how people are going to react. So I'm glad it went well, and I hope I get to photograph their wedding someday.”Estill is working on putting together a questionnaire to better match people up in future shoots.You can visit her Facebook, Instagram, or website for further information or inquire about being part of an upcoming shoot.This story was first reported by Michael Martin at WXMI in Grand Rapids, Michigan. 3038
A new political ad could be masquerading as an official correction to the sample ballots that hit mailboxes across San Diego.It's the latest swing in the fight over the state's recent 12-cent per gallon gas tax hike.The mailer, sent to two million Californians mail-in voters, is titled "Election Ballot **Correction**" and says the correct title for Proposition 6 should be "Gas Tax Repeal Initiative.”Proposition 6 is on the November ballot to repeal the state's gas tax increase and new vehicle registration fees. The state raised the levies last year to generate billions of dollars in infrastructure projects. Dave McCulloch, communications director for Reform California, which sent out the mailer, says the Attorney General's ballot language does not make that clear. It instead reads that Prop 6 "eliminates certain road repair and transportation funding...repeals a 2017 transportation law's taxes and fees designated for road repairs and public transportation."We sent out this mailer to make sure that everyone in California knows Prop 6 is the gas tax repeal," McCulloch said. "We know that when people discover that Yes on 6 means to repeal the gas tax, they're much more in favor of it because they realize what it is.”The Attorney General's office did not immediately respond to a request for comment. The mailer instructs voters to keep it with their sample ballot mailed to them. Thad Kousser, a political scientist at UC San Diego, said ballot language is often contentions. But he noted the gas tax increase has been so heavily covered that most people will associate with Prop 6. He says this mailer reinforces that. "When they get to their ballot on election day, they're not going to see repeal the gas tax," Kousser said. "They're going to see a proposal written legal language that says exactly what this bill does, which is it changes transportation fees and cuts funding for things." That mailer does include disclosures that it's not official and that Reform California paid for it. Still, Catherine hill, a local spokeswoman for the No on 6 campaign, called it deceptive."It's made to look like a registrar of voters piece, so it's made to look official, so it's misleading," she said. The San Diego Association of Governments says more than 200 million dollars in funds from the tax increase have already been awarded to the region. 2399
A Rikers Island inmate is back in police custody in New York after attempting to escape on Thursday, officials said.Around 12:30 p.m., the detainee climbed a recreation yard fence and ran to the shoreline, Deputy Commissioner of Public Information Peter Thorne said.The detainee was apprehended by K-9 Correction Officers Larry McCardle and Gregory Braska, Correction Officers' Benevolent Association President Elias Husamudeen said."These two brave officers immediately jumped into action to bring the inmate back into custody without any regards for their own safety," Husamudeen said. "We proudly salute them for their bravery and for reminding the public the critical role Correction Officers play every day in maintaining public safety.”Husamudeen is scheduled to speak Thursday afternoon.This is a developing story. Check back for updates.WPIX's Aliza Chasan was first to report this story. 904
A third leading candidate COVID-19 vaccine has entered a final stage of human testing in the United States. AstraZeneca announced Monday its potential COVID-19 vaccine has entered final trials in the U.S. to test the effectiveness and safety of the product. The Cambridge, England-based company said the trial will involve up to 30,000 adults from various racial, ethnic and geographic groups. The potential vaccine was invented by the University of Oxford and an associated company, Vaccitech.AstraZeneca said development of the vaccine known as AZD1222 is moving ahead globally with late-stage trials in the U.K., Brazil and South Africa. Further trials are planned in Japan and Russia.“To have just one vaccine enter the final stage of trials eight months after discovering a virus would be a remarkable achievement; to have three at that point with more on the way is extraordinary,” Health and Human Services Secretary Alex Azar said in a statement.Two other vaccine candidates began final testing this summer in tens of thousands of people in the U.S. One was created by the National Institutes of Health and manufactured by Moderna Inc., and the other developed by Pfizer Inc. and Germany’s BioNTech. 1215